-
China injects volunteers with test vaccine, showing strong research capability
globaltimes
March 23, 2020
Chinese volunteers in a clinical trial for the first COVID-19 vaccine developed by the country's military scientists received injections on Friday ...
-
EC offers €80m to CureVac for COVID-19 vaccine development
europeanpharmaceuticalreview
March 20, 2020
The European Commision (EC) has announced €80 million of support to aid in the R&D and production of a COVID-19 coronavirus vaccine.
-
Novel thermally-stable COVID-19 vaccine capsule developed
europeanpharmaceuticalreview
March 20, 2020
Developers have announced that they are ready to manufacture and formulate an innovative novel coronavirus vaccine capsule.
-
Emergent BioSolutions and Vaxart partner on oral coronavirus vaccine
pharmaceutical-technology
March 20, 2020
Emergent BioSolutions has agreed to provide molecule-to-market contract development and manufacturing (CDMO) services for Vaxart’s oral vaccine candidate against Covid-19 coronavirus infection.
-
CanSinoBIO, Synairgen get regulatory approval for Covid-19 trials
pharmaceutical-technology
March 20, 2020
China-based CanSino Biologics has received regulatory approval to conduct Phase I clinical trial of recombinant novel coronavirus vaccine (adenovirus type 5 vector) candidate.
-
Covid-19: Entos and Takis to work on separate vaccines
pharmaceutical-technology
March 20, 2020
Entos Pharmaceuticals is set to develop a DNA vaccine for Covid-19 coronavirus infection using its Fusogenix drug delivery platform.
-
IMV to progress clinical development of Covid-19 vaccine
pharmaceutical-technology
March 20, 2020
IMV has initiated plans to progress the clinical development of a Covid-19 vaccine candidate, to determine the clinical safety and immunogenicity.
-
Vaccine development key to beating outbreak, says Zhong
chinadaily
March 19, 2020
The COVID-19 pandemic cannot be controlled by the herd immunity strategy and vaccines will be the key to ultimately tackling the virus, said Zhong Nanshan, a prominent Chinese expert in respiratory diseases.
-
Moderna Leads Coronavirus Vaccine Charge
contractpharma
March 19, 2020
First participant dosed in NIH-led Phase 1 study of mRNA vaccine against novel coronavirus.
-
CEPI calls for $2bn of funding for coronavirus vaccine
europeanpharmaceuticalreview
March 18, 2020
According to CEPI, $2 billion is needed to progress coronavirus vaccines through development as quickly as possible, leading the organisation to call for donations.